Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilze Bot

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Journal of Cellular and Molecular Medicine|February 1, 2012
Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat modelAlexander Schuh, Andreas Kroh, Simone Konschalla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosisAmanda C Foks, Gijs H M van Puijvelde, Ilze Bot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2013
Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulationSaskia C A de Jager, Ilze Bot, Adriaan O Kraaijeveld, et al.
Atherosclerosis|March 4, 2010
Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differentlyVivian de Waard, Ilze Bot, Saskia C A de Jager, et al.
Cardiovascular Research|August 10, 2010
Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- miceIlze Bot, Martine Bot, Sandra H van Heiningen, et al.
Cardiovascular Research|November 19, 2008
Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient miceJian Guo, Ilze Bot, Ramon de Nooijer, et al.
Vascular Pharmacology|March 23, 2023
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcificationNikolaos T Skenteris, Esmeralda Hemme, Lucie Delfos, et al.
Circulation Research|November 26, 2011
Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitorHaixiang Yu, Ilze Bot, Karen Sliedregt, et al.
Journal of Lipid Research|February 12, 2013
Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammationMartine Bot, Saskia C A de Jager, Luke MacAleese, et al.
Circulation Research|November 21, 2009
The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosisIlze Bot, Saskia C A de Jager, Martine Bot, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Journal of Cellular and Molecular Medicine|February 1, 2012
Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat modelAlexander Schuh, Andreas Kroh, Simone Konschalla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 27, 2013
Interruption of the OX40-OX40 ligand pathway in LDL receptor-deficient mice causes regression of atherosclerosisAmanda C Foks, Gijs H M van Puijvelde, Ilze Bot, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 5, 2013
Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulationSaskia C A de Jager, Ilze Bot, Adriaan O Kraaijeveld, et al.
Atherosclerosis|March 4, 2010
Systemic MCP1/CCR2 blockade and leukocyte specific MCP1/CCR2 inhibition affect aortic aneurysm formation differentlyVivian de Waard, Ilze Bot, Saskia C A de Jager, et al.
Cardiovascular Research|August 10, 2010
Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- miceIlze Bot, Martine Bot, Sandra H van Heiningen, et al.
Cardiovascular Research|November 19, 2008
Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient miceJian Guo, Ilze Bot, Ramon de Nooijer, et al.
Vascular Pharmacology|March 23, 2023
Mast cells participate in smooth muscle cell reprogramming and atherosclerotic plaque calcificationNikolaos T Skenteris, Esmeralda Hemme, Lucie Delfos, et al.
Circulation Research|November 26, 2011
Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitorHaixiang Yu, Ilze Bot, Karen Sliedregt, et al.
Journal of Lipid Research|February 12, 2013
Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammationMartine Bot, Saskia C A de Jager, Luke MacAleese, et al.
Circulation Research|November 21, 2009
The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosisIlze Bot, Saskia C A de Jager, Martine Bot, et al.
Pageof 13